Endocrine Disruption and Human Health
portes grátis
Endocrine Disruption and Human Health
Darbre, Philippa D.
Elsevier Science Publishing Co Inc
09/2021
538
Mole
Inglês
9780128219850
15 a 20 dias
1090
Descrição não disponível.
SECTION 1 OVERVIEW and SCOPE 1. What is endocrine disruption? 2. Which chemicals are endocrine disruptors?
SECTION 2 MECHANISMS and ASSAY SYSTEMS 3. Environmental oestrogens: Disrupters of oestrogen action 4. Disrupters of androgen action 5. Assay systems for studying endocrine disruption 6. Non-monotonic responses in endocrine disruption 7. Endocrine disrupters as modifiers of endogenous hormone synthesis
SECTION 3 CONCERNS FOR HUMAN HEALTH 8. Endocrine disruption and female reproductive health 9. Endocrine disruption and breast cancer 10. Endocrine disruption and male reproductive health 11. Endocrine disruption and prostate cancer 12. Endocrine disruption and thyroid disease 13. Endocrine disruption of adrenal function 14. Endocrine disruption of developmental pathways and children's health 15. Endocrine disruption of immune function 16. Endocrine disruption and obesity, metabolic syndrome and type 2 diabetes 17. Endocrine disruption and cardiovascular disease 18. Transgenerational effects of endocrine disruption 19. Regulatory considerations
SECTION 2 MECHANISMS and ASSAY SYSTEMS 3. Environmental oestrogens: Disrupters of oestrogen action 4. Disrupters of androgen action 5. Assay systems for studying endocrine disruption 6. Non-monotonic responses in endocrine disruption 7. Endocrine disrupters as modifiers of endogenous hormone synthesis
SECTION 3 CONCERNS FOR HUMAN HEALTH 8. Endocrine disruption and female reproductive health 9. Endocrine disruption and breast cancer 10. Endocrine disruption and male reproductive health 11. Endocrine disruption and prostate cancer 12. Endocrine disruption and thyroid disease 13. Endocrine disruption of adrenal function 14. Endocrine disruption of developmental pathways and children's health 15. Endocrine disruption of immune function 16. Endocrine disruption and obesity, metabolic syndrome and type 2 diabetes 17. Endocrine disruption and cardiovascular disease 18. Transgenerational effects of endocrine disruption 19. Regulatory considerations
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Addison's disease; Additive effects; Adipogenesis; Adrenal cortex; Adrenal insufficiency; Adverse outcome pathway; Air freshener; Air pollution; Aldosterone; Alkylphenol; Androgen action; Androgen receptor; Antiandrogens; Antibiotics; Antiperspirant; Aromatase; Aryl hydrocarbon receptor; Benzophenone; Bioassays; Biological availability; Biphasic; Bisphenol A; BPA; Breast cancer; Breast cyst; Breast fibroadenoma; Cancer; Cardiovascular disease; Catastrophe theory; Cervical cancer; Chemicals; Child development; Cigarette smoking; Competitive binding assay; Constitutive androstane receptor; Corticosterone; Cortisol; Cosmetics; Critical windows of susceptibility; Cryptorchidism; Cyclic volatile methylsiloxane; Cytochrome P450Dexamethasone; Deodorant; Dermal absorption; Diabetes; Diethylphthalate; Diethylstilbestrol (DES)Endocrine disrupter; Diethylstilbestrol (DES)Endocrine disruption; Diethylstilbestrol (DES)Endometriosis; Dihydrotestosterone (DHT)Steroidogenesis; Dioxin; Dose response; Drinking water; EDSP; Endocrine disrupter; Endocrine disruption; Endocrine-disrupting chemical (EDC)Human health; Endocrine-disrupting chemicals (EDCs)Fragrance; Endocrine-disrupting chemicals; Endocrinology; Endometrial cancer; Endpoint; Environmental estrogen; Estrogen action; Estrogen; Ethinylestradiol; Fertility; Fetal development; Fibroid; Flare; Food contaminants; Food packaging; Genomics; Glucocorticoid receptor; Green chemistry; Guideline study; Gut microbiome-liver axis; Gut microbiota; Gut-brain axis; Gynecomastia; Hallmarks of cancer; Hazard; Hops; Hormone receptor; Hormone; Human exposure; Hypospadias; Hypothalamic-pituitary-thyroid (HPT) axis; Hypothyroidism; Immune dysfunction; In vitro tests; In vivo tests; Individual susceptibility; Indoor air; Inflammation; Intrauterine position; Latency period; Long term; Low dose; MCF-7 cells; Menopause; Menstruation; Metabolic disease; Metabolic syndrome; Metabolism; Mineralocorticoid receptor; Mixtures; Mycoestrogen; Neurodevelopment; Nongovernment organization; Nonmonotonic response; Nonpersistent chemicals; Obesity; Obesogen; OECD Test Guidelines; Organochlorine; Organometals; Outdoor air; Ovarian cancer; Paraben; Parabens; Particulate matter; Peroxisome proliferator-activated receptor; Persistent organic pollutants (POPs)Prenatal exposures and childhood exposures; Persistent organic pollutants; Personal care products (PCPs)Phytoestrogen; Personal care products; Pharmaceuticals; Phthalate; Phytoestrogen and steroid; Phytoestrogen; Phytoestrogens; Polycystic ovary and puberty; Precautionary principle; Pregnane X receptor; Premature ovarian failure (POF)Progesterone receptor; Progestin and prostaglandin; Prostate cancer; Prostatic hyperplasia; Proteomics; Puberty; Receptor-mediated mechanisms; Regrettable substitution; Reporter genes and uterotrophic assay; Reproduction; Reproductive tract; Risk and weight of evidence; Risk assessment; Sewage; Sex differences; Something from nothing; Spermatogenesis and testicular dysgenesis syndrome; Steroid estrogens; Steroid; Sustainability; Sustainable chemistry; T3T4Thyroid hormone; Testicular cancer; Testosterone; Thyroid hormone receptor; Thyroid hypertrophy; Thyroid inhibition; Thyroid peroxidase; Thyroid tumor; Thyroid; Thyroid-stimulating hormone (TSH) and thyroid hormone disruption; Thyroid-stimulating hormone (TSH)Uridine diphosphate glucuronyltransferase (UDP-GT)Tissue microenvironment; Toxicity; Toxicology; Traffic-related pollution; Transgenerational effects; Treatment; Triclosanand ultraviolet (UV) filter; Type 2 diabetes; Vinclozolin and prochloraz; Volatile organic; Wastewater; Water
SECTION 1 OVERVIEW and SCOPE 1. What is endocrine disruption? 2. Which chemicals are endocrine disruptors?
SECTION 2 MECHANISMS and ASSAY SYSTEMS 3. Environmental oestrogens: Disrupters of oestrogen action 4. Disrupters of androgen action 5. Assay systems for studying endocrine disruption 6. Non-monotonic responses in endocrine disruption 7. Endocrine disrupters as modifiers of endogenous hormone synthesis
SECTION 3 CONCERNS FOR HUMAN HEALTH 8. Endocrine disruption and female reproductive health 9. Endocrine disruption and breast cancer 10. Endocrine disruption and male reproductive health 11. Endocrine disruption and prostate cancer 12. Endocrine disruption and thyroid disease 13. Endocrine disruption of adrenal function 14. Endocrine disruption of developmental pathways and children's health 15. Endocrine disruption of immune function 16. Endocrine disruption and obesity, metabolic syndrome and type 2 diabetes 17. Endocrine disruption and cardiovascular disease 18. Transgenerational effects of endocrine disruption 19. Regulatory considerations
SECTION 2 MECHANISMS and ASSAY SYSTEMS 3. Environmental oestrogens: Disrupters of oestrogen action 4. Disrupters of androgen action 5. Assay systems for studying endocrine disruption 6. Non-monotonic responses in endocrine disruption 7. Endocrine disrupters as modifiers of endogenous hormone synthesis
SECTION 3 CONCERNS FOR HUMAN HEALTH 8. Endocrine disruption and female reproductive health 9. Endocrine disruption and breast cancer 10. Endocrine disruption and male reproductive health 11. Endocrine disruption and prostate cancer 12. Endocrine disruption and thyroid disease 13. Endocrine disruption of adrenal function 14. Endocrine disruption of developmental pathways and children's health 15. Endocrine disruption of immune function 16. Endocrine disruption and obesity, metabolic syndrome and type 2 diabetes 17. Endocrine disruption and cardiovascular disease 18. Transgenerational effects of endocrine disruption 19. Regulatory considerations
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Addison's disease; Additive effects; Adipogenesis; Adrenal cortex; Adrenal insufficiency; Adverse outcome pathway; Air freshener; Air pollution; Aldosterone; Alkylphenol; Androgen action; Androgen receptor; Antiandrogens; Antibiotics; Antiperspirant; Aromatase; Aryl hydrocarbon receptor; Benzophenone; Bioassays; Biological availability; Biphasic; Bisphenol A; BPA; Breast cancer; Breast cyst; Breast fibroadenoma; Cancer; Cardiovascular disease; Catastrophe theory; Cervical cancer; Chemicals; Child development; Cigarette smoking; Competitive binding assay; Constitutive androstane receptor; Corticosterone; Cortisol; Cosmetics; Critical windows of susceptibility; Cryptorchidism; Cyclic volatile methylsiloxane; Cytochrome P450Dexamethasone; Deodorant; Dermal absorption; Diabetes; Diethylphthalate; Diethylstilbestrol (DES)Endocrine disrupter; Diethylstilbestrol (DES)Endocrine disruption; Diethylstilbestrol (DES)Endometriosis; Dihydrotestosterone (DHT)Steroidogenesis; Dioxin; Dose response; Drinking water; EDSP; Endocrine disrupter; Endocrine disruption; Endocrine-disrupting chemical (EDC)Human health; Endocrine-disrupting chemicals (EDCs)Fragrance; Endocrine-disrupting chemicals; Endocrinology; Endometrial cancer; Endpoint; Environmental estrogen; Estrogen action; Estrogen; Ethinylestradiol; Fertility; Fetal development; Fibroid; Flare; Food contaminants; Food packaging; Genomics; Glucocorticoid receptor; Green chemistry; Guideline study; Gut microbiome-liver axis; Gut microbiota; Gut-brain axis; Gynecomastia; Hallmarks of cancer; Hazard; Hops; Hormone receptor; Hormone; Human exposure; Hypospadias; Hypothalamic-pituitary-thyroid (HPT) axis; Hypothyroidism; Immune dysfunction; In vitro tests; In vivo tests; Individual susceptibility; Indoor air; Inflammation; Intrauterine position; Latency period; Long term; Low dose; MCF-7 cells; Menopause; Menstruation; Metabolic disease; Metabolic syndrome; Metabolism; Mineralocorticoid receptor; Mixtures; Mycoestrogen; Neurodevelopment; Nongovernment organization; Nonmonotonic response; Nonpersistent chemicals; Obesity; Obesogen; OECD Test Guidelines; Organochlorine; Organometals; Outdoor air; Ovarian cancer; Paraben; Parabens; Particulate matter; Peroxisome proliferator-activated receptor; Persistent organic pollutants (POPs)Prenatal exposures and childhood exposures; Persistent organic pollutants; Personal care products (PCPs)Phytoestrogen; Personal care products; Pharmaceuticals; Phthalate; Phytoestrogen and steroid; Phytoestrogen; Phytoestrogens; Polycystic ovary and puberty; Precautionary principle; Pregnane X receptor; Premature ovarian failure (POF)Progesterone receptor; Progestin and prostaglandin; Prostate cancer; Prostatic hyperplasia; Proteomics; Puberty; Receptor-mediated mechanisms; Regrettable substitution; Reporter genes and uterotrophic assay; Reproduction; Reproductive tract; Risk and weight of evidence; Risk assessment; Sewage; Sex differences; Something from nothing; Spermatogenesis and testicular dysgenesis syndrome; Steroid estrogens; Steroid; Sustainability; Sustainable chemistry; T3T4Thyroid hormone; Testicular cancer; Testosterone; Thyroid hormone receptor; Thyroid hypertrophy; Thyroid inhibition; Thyroid peroxidase; Thyroid tumor; Thyroid; Thyroid-stimulating hormone (TSH) and thyroid hormone disruption; Thyroid-stimulating hormone (TSH)Uridine diphosphate glucuronyltransferase (UDP-GT)Tissue microenvironment; Toxicity; Toxicology; Traffic-related pollution; Transgenerational effects; Treatment; Triclosanand ultraviolet (UV) filter; Type 2 diabetes; Vinclozolin and prochloraz; Volatile organic; Wastewater; Water
